Reto Naef

4 Patents

• US125023932025

  Dual Mode of Action Soluble Guanylate Cyclase Activators and Phosphodiesterase Inhibitors and Uses Thereof

  TOPADUR PHARMA AG

  0 cites
• US123515852025

  2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone Derivatives as Phosphodiesterase Inhibitors and Uses Thereof

  TOPADUR PHARMA AG

  0 cites
• US119052932024

  Dual Mode of Action Soluble Guanylate Cyclase Activators and Phosphodiesterase Inhibitors and Uses Thereof

  TOPADUR PHARMA AG

  0 cites
• US118978902024

  2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone Derivatives as Phosphodiesterase Inhibitors and Uses Thereof

  TOPADUR PHARMA AG

  0 cites